Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"
By
ecancer
FEATURING
Jennifer Knox
By
ecancer
FEATURING
Jennifer Knox
196 views
June 20, 2024
Comments 0
Login to view comments.
Click here to Login